IFIH1 and clinically amyopathic dermatomyositis: The anti-MDA5 antibody can be identified in patients with classic dermatomyositis (DM); however, those with anti-MDA5 antibody (anti-MDA5 [+]) DM/CADM rarely present with critical muscle symptoms, making early detection challenging (4).